Arcturus Therapeutics, Inc.
10628 Science Center Drive
Suite 250
San Diego
CA
92121
United States
1 article with Arcturus Therapeutics, Inc.
-
Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6/19/2019
Scope of the collaboration expands to include up to 12 rare disease targets and includes Arcturus nucleic acid technologies to enable mRNA, DNA, and siRNA therapeutics